Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Wednesday. The firm set a “hold” rating on the stock.

Retractable Technologies Stock Up 3.5 %

Retractable Technologies stock opened at $0.79 on Wednesday. The stock’s 50 day moving average price is $0.67 and its 200 day moving average price is $0.83. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.34. The company has a market cap of $23.60 million, a PE ratio of -1.46 and a beta of 1.94. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.